PDP Holdings is a company that works with surgeons, hospitals and device manufacturers to provide high quality implants at a lower cost. Their business model allows surgeons to select implants — oftentimes from the same suppliers they already use in the operating room — and purchase them directly from the manufacturer, cutting out the distributor and sales rep as the "middle men" in the equation.
Here are three benefits of a PDP's direct purchase implant model:
1. Hospital benefits. Joseph Truhe, senior vice president and general counsel for PDP Holdings, says hospitals can save 10 to 20 percent or more, on these surgical devices, even for the identical supplier. In one case, the company was able to save a Texas hospital 40 percent on devices on a DRG comparison, accounting for the elimination of "upselling" in the OR and the use of non-premium equivalents. Such savings are particularly attractive if the hospital is participating in accountable care organizations, bundled payments or another type of risk-sharing arrangement to lower costs and provide better care
2. Surgeon benefits. Within the company's model, surgeons partner with PDP to lower supply chain costs and control physician preference item decisions. In return, they share in the savings generated by the model. Mr. Truhe says that since physicians take real risk, maintain independence from manufacturers, and operate under strict compliance requirements, this type of venture complies with current regulatory guidance from the Office of the Inspector General.
3. Device company benefits. PDP holds an event where device companies can display their products and invites participating surgeons to examine their options and then make decisions about which devices to use. This access to surgeons is highly sought after and shows that device companies are willing to partner with physicians in their cost-cutting initiatives going forward.
Orthopedic & Spine Industry Company to Know: PDP HoldingsWritten by Laura Dyrda | Thursday, 15 November 2012 16:39
One of the biggest expenses in orthopedic and spine surgery is device and implant costs. Providers often pay a premium for name-brand products, many of which are actually commodities, and the sales representatives that come along with them. However, downward pressure on reimbursement is forcing providers to examine healthcare costs and cut those costs wherever necessary to provide true value-based healthcare.
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies here.
Most Read - Devices & Implants
- Medtronic, Xtant Medical, Titan Spine & more: 13 key notes
- Medtronic finds its place in orthopedic market with knee-implant service: 5 observations
- 7 new spine, orthopedic device launches & releases — Nov. 23, 2016
- Zimmer Biomet, Amendia & more — 3 recent device company acquisitions & partnerships
- FDA clears Xtant Medical's Xsert Lumbar Expandable Interbody System: 5 highlights
Top 40 Articles from the Past 6 Months
- 20 new MIS spine devices in 2016
- 44 MIS spine devices to know | 2016
- 21 smart spine surgeons with gifted business minds
- Top 12 most-liked spine surgeons on the internet
- Police investigate death of American Spine Center's physician accused in federal kickback scheme: 6 things to know
- Consumer Reports: 34 top-rated US hospitals for hip replacements
- Suicide likely cause of Dr. Sandeep Sherlekar's death, police report shows: 6 things to know
- Dr. George Rappard performs 1st US MIS procedure with Sony heads-up display: 5 observations
- Annual & hourly orthopedic surgeon salary — 10 latest statistics
- Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
- 12 statistics on social media's presence in the healthcare space
- 5 key notes on the Zimmer Biomet-LDR acquisition & its impact on Texas
- 38 female spine surgeon leaders to know
- Dr. Gregory Sherr sues HealthEast, CentraCare & 6 neurosurgeons for allegedly ruining his reputation & career — 6 things to know
- Oregon spine surgeon implicated in $22M lawsuit for paralyzing patient with dropped instrument: 5 things to know
- UPMC to pay $2.5M+ to settle neurosurgery-related False Claims Act violation allegations: 7 things to know
- 4 North Carolina orthopedic practices merge to create EmergeOrtho: 5 key notes
- US News & World Report: Top 10 hospitals for orthopedics
- 7 things to know about Mazor Robotics & Medtronic's plans to roll out Mazor X
- The state of minimally invasive spine surgery: Dr. Frank Phillips on devices, payment & outpatient ASCs
- 11 highest-paying states for orthopedic surgeons: New Jersey tops the list at $494.5k
- Beyond the implant — DePuy Synthes pushes innovation inside & out of the OR
- Zimmer Biomet jumps into robotics with MedTech acquisition: 5 things to know
- Orthopedic surgeon Dr. Michael Russin dies following plane crash: 5 key notes
- 34 latest trends in the global orthopedic devices market
- 21 statistics and facts for orthopedic surgeons — compensation, net worth and more
- 19 more things to know about orthopedic bundled payments — September 2016
- Are Stryker's hip implants about to be recalled?
- Trump or Hillary? The physicians have voted
- FDA regulation, insurance coverage: Dr. Raj N. Sureja talks challenges in regenerative medicine
- Do you know what patients really care about when choosing a spine surgeon?
- 13 facts and statistics on Baby Boomers for spine surgeons to know
- 5 trends for orthopedic surgeons to watch in 2017
- 3 orthopedic clinics to pay $2.39M to settle False Claims Act allegations: 5 things to know
- 10 thoughts and statistics on medical malpractice claims against orthopedists
- Evolutionary vs. revolutionary: The future of surgical devices and spine surgery
- Robotics is here to stay — Drs. Kornelis Poelstra & Dennis Devito on working with Mazor technology
- UCLA pays $8.5M to settle 2 lawsuits after undisclosed spine surgeon relationship with Medtronic: 5 key notes
- Medtronic, SeaSpine, Zimmer Biomet & more: 17 key notes
- The efficacy of electrical bone stimulators & ultrasound for bone healing — Dr. Mohit Bhandari weighs in with new evidence